1ANG
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN REVEALS THE STRUCTURAL BASIS FOR ITS FUNCTIONAL DIVERGENCE FROM RIBONUCLEASE | Descriptor: | ANGIOGENIN | Authors: | Acharya, K.R, Allen, S, Shapiro, R, Riordan, J.F, Vallee, B.L. | Deposit date: | 1994-01-18 | Release date: | 1995-04-20 | Last modified: | 2011-07-13 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc.Natl.Acad.Sci.USA, 91, 1994
|
|
1ALC
| |
1AGI
| |
1BBT
| METHODS USED IN THE STRUCTURE DETERMINATION OF FOOT AND MOUTH DISEASE VIRUS | Descriptor: | FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP1), FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP2), FOOT-AND-MOUTH DISEASE VIRUS (SUBUNIT VP3), ... | Authors: | Acharya, K.R, Fry, E.E, Logan, D.T, Stuart, D.I. | Deposit date: | 1992-05-18 | Release date: | 1994-01-31 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (2.6 Å) | Cite: | Methods used in the structure determination of foot-and-mouth disease virus. Acta Crystallogr.,Sect.A, 49, 1993
|
|
2QIL
| |
1QIL
| |
6GPB
| |
1STE
| |
1GPB
| |
1LCL
| CHARCOT-LEYDEN CRYSTAL PROTEIN | Descriptor: | LYSOPHOSPHOLIPASE | Authors: | Acharya, K.R, Leonidas, D.D. | Deposit date: | 1996-01-18 | Release date: | 1997-01-11 | Last modified: | 2024-02-14 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Crystal structure of human Charcot-Leyden crystal protein, an eosinophil lysophospholipase, identifies it as a new member of the carbohydrate-binding family of galectins. Structure, 3, 1995
|
|
1A4V
| ALPHA-LACTALBUMIN | Descriptor: | ALPHA-LACTALBUMIN, CALCIUM ION | Authors: | Chandra, N, Acharya, K.R. | Deposit date: | 1998-02-05 | Release date: | 1999-04-27 | Last modified: | 2011-07-13 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Structural evidence for the presence of a secondary calcium binding site in human alpha-lactalbumin. Biochemistry, 37, 1998
|
|
3SEB
| STAPHYLOCOCCAL ENTEROTOXIN B | Descriptor: | STAPHYLOCOCCAL ENTEROTOXIN B | Authors: | Papageorgiou, A.C, Acharya, K.R. | Deposit date: | 1997-11-26 | Release date: | 1998-05-27 | Last modified: | 2024-04-03 | Method: | X-RAY DIFFRACTION (1.48 Å) | Cite: | Crystal structure of microbial superantigen staphylococcal enterotoxin B at 1.5 A resolution: implications for superantigen recognition by MHC class II molecules and T-cell receptors. J.Mol.Biol., 277, 1998
|
|
5NJL
| Cwp2 from Clostridium difficile | Descriptor: | Cell surface protein (Putative S-layer protein), SULFATE ION | Authors: | Bradshaw, W.J, Kirby, J.M, Roberts, A.K, Shone, C.C, Acharya, K.R. | Deposit date: | 2017-03-29 | Release date: | 2017-07-05 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.9 Å) | Cite: | Cwp2 from Clostridium difficile exhibits an extended three domain fold and cell adhesion in vitro. FEBS J., 284, 2017
|
|
5OQ3
| High resolution structure of the functional region of Cwp19 from Clostridium difficile | Descriptor: | 1,2-ETHANEDIOL, CHLORIDE ION, Cwp19, ... | Authors: | Bradshaw, W.J, Kirby, J.M, Roberts, A.K, Shone, C.C, Acharya, K.R. | Deposit date: | 2017-08-10 | Release date: | 2017-11-01 | Last modified: | 2024-01-17 | Method: | X-RAY DIFFRACTION (1.35 Å) | Cite: | The molecular structure of the glycoside hydrolase domain of Cwp19 from Clostridium difficile. FEBS J., 284, 2017
|
|
5OQ2
| Se-SAD structure of the functional region of Cwp19 from Clostridium difficile | Descriptor: | 1,2-ETHANEDIOL, Cwp19, PHOSPHATE ION | Authors: | Bradshaw, W.J, Kirby, J.M, Roberts, A.K, Shone, C.C, Acharya, K.R. | Deposit date: | 2017-08-10 | Release date: | 2017-11-01 | Last modified: | 2017-12-27 | Method: | X-RAY DIFFRACTION (2.3 Å) | Cite: | The molecular structure of the glycoside hydrolase domain of Cwp19 from Clostridium difficile. FEBS J., 284, 2017
|
|
1B1I
| CRYSTAL STRUCTURE OF HUMAN ANGIOGENIN | Descriptor: | CITRIC ACID, HYDROLASE ANGIOGENIN | Authors: | Leonidas, D.D, Acharya, K.R. | Deposit date: | 1998-11-20 | Release date: | 1999-04-02 | Last modified: | 2023-08-09 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Refined crystal structures of native human angiogenin and two active site variants: implications for the unique functional properties of an enzyme involved in neovascularisation during tumour growth. J.Mol.Biol., 285, 1999
|
|
1B1Z
| STREPTOCOCCAL PYROGENIC EXOTOXIN A1 | Descriptor: | PROTEIN (TOXIN) | Authors: | Papageorgiou, A.C, Acharya, K.R. | Deposit date: | 1998-11-24 | Release date: | 1999-11-24 | Last modified: | 2024-04-03 | Method: | X-RAY DIFFRACTION (2.57 Å) | Cite: | Structural basis for the recognition of superantigen streptococcal pyrogenic exotoxin A (SpeA1) by MHC class II molecules and T-cell receptors. EMBO J., 18, 1999
|
|
1BKZ
| |
1C5D
| THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR | Descriptor: | MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR | Authors: | Kontou, M, Leonidas, D.D, Vatzaki, E.H, Tsantili, P, Mamalaki, A, Oikonomakos, N.G, Acharya, K.R, Tzartos, S.J. | Deposit date: | 1999-11-17 | Release date: | 1999-12-03 | Last modified: | 2023-08-09 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | The crystal structure of the Fab fragment of a rat monoclonal antibody against the main immunogenic region of the human muscle acetylcholine receptor. Eur.J.Biochem., 267, 2000
|
|
8RP4
| Alpha-Methylacyl-CoA racemase from Mycobacterium tuberculosis (D156A mutant) | Descriptor: | 1,2-ETHANEDIOL, Alpha-methylacyl-CoA racemase, DI(HYDROXYETHYL)ETHER | Authors: | Mojanaga, O.O, Acharya, K.R, Lloyd, M.D. | Deposit date: | 2024-01-12 | Release date: | 2024-04-10 | Method: | X-RAY DIFFRACTION (1.64 Å) | Cite: | alpha-Methylacyl-CoA Racemase from Mycobacterium tuberculosis -Detailed Kinetic and Structural Characterization of the Active Site. Biomolecules, 14, 2024
|
|
8RMW
| Alpha-Methylacyl-CoA racemase from Mycobacterium tuberculosis. | Descriptor: | 1,2-ETHANEDIOL, Alpha-methylacyl-CoA racemase, DI(HYDROXYETHYL)ETHER | Authors: | Mojanaga, O.O, Acharya, K.R, Lloyd, M.D. | Deposit date: | 2024-01-09 | Release date: | 2024-04-10 | Method: | X-RAY DIFFRACTION (1.65 Å) | Cite: | alpha-Methylacyl-CoA Racemase from Mycobacterium tuberculosis -Detailed Kinetic and Structural Characterization of the Active Site. Biomolecules, 14, 2024
|
|
8RP3
| |
8RP5
| Alpha-Methylacyl-CoA racemase from Mycobacterium tuberculosis (E241A mutant) | Descriptor: | 1,2-ETHANEDIOL, Alpha-methylacyl-CoA racemase, TRIETHYLENE GLYCOL | Authors: | Mojanaga, O.O, Acharya, K.R, Lloyd, M.D. | Deposit date: | 2024-01-12 | Release date: | 2024-04-10 | Method: | X-RAY DIFFRACTION (1.85 Å) | Cite: | alpha-Methylacyl-CoA Racemase from Mycobacterium tuberculosis -Detailed Kinetic and Structural Characterization of the Active Site. Biomolecules, 14, 2024
|
|
7Q26
| Crystal structure of Angiotensin-1 converting enzyme N-domain in complex with dual ACE/NEP inhibitor AD013 | Descriptor: | (2~{S},5~{R})-5-(4-methylphenyl)-1-[2-[[(2~{S})-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]ethanoyl]pyrrolidine-2-carboxylic acid, 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Cozier, G.E, Acharya, K.R. | Deposit date: | 2021-10-23 | Release date: | 2022-02-16 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | Probing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin Inhibition. J.Med.Chem., 65, 2022
|
|
7Q29
| Crystal structure of Angiotensin-1 converting enzyme C-domain in complex with dual ACE/NEP inhibitor AD013 | Descriptor: | (2~{S},5~{R})-5-(4-methylphenyl)-1-[2-[[(2~{S})-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]ethanoyl]pyrrolidine-2-carboxylic acid, 1,2-ETHANEDIOL, 2-acetamido-2-deoxy-beta-D-glucopyranose, ... | Authors: | Cozier, G.E, Acharya, K.R. | Deposit date: | 2021-10-23 | Release date: | 2022-02-16 | Last modified: | 2024-01-31 | Method: | X-RAY DIFFRACTION (1.6 Å) | Cite: | Probing the Requirements for Dual Angiotensin-Converting Enzyme C-Domain Selective/Neprilysin Inhibition. J.Med.Chem., 65, 2022
|
|